Abbott India Share Price Gains After Q4 Net Profit, Revenue Rise
Abbott India revenue was up 9% at Rs 1,633 crore during the January-March period, compared to Rs 1,494 crore in the year-ago period.
Share price for Abbott India Ltd. moved up nearly 4% on Friday, after the company reported revenue and net profit growth in the fourth quarter of fiscal 2025. The stock climbed as high as Rs 31,500 apiece to trade at high volume.
Net profit increased 14.7% at Rs 359 crore in the fourth quarter, compared to Rs 313 crore in the same period last year. This was ahead of Bloomberg estimate of Rs 237 crore.
The medical tech company's revenue was up 9% at Rs 1,633 crore during the January-March period, compared to Rs 1,494 crore in the year-ago period.
Ebitda rose 15% to Rs 439 crore, compared to Rs 381 crore last year, beating Bloomberg estimate of Rs 399 crore. Ebitda margin expanded to 26.9% from 25.5% in the same quarter last year.
Abbott Share Price
Shares of Abbott rose as much as 3.86% to Rs 31,500 apiece, the highest level since March 7, 2025. They pared gains to trade 1.93% higher at Rs 30,915 apiece, as of 10:35 a.m. This compares to a 0.21% decline in the NSE Nifty 50.
The stock has risen 3.88% on a year-to-date basis, and 16.23% in the last 12 months. Total traded volume so far in the day stood at 8.3 times its 30-day average. The relative strength index was at 50.18.
Out of eight analysts tracking the company, seven maintain a 'buy' rating, and one suggests 'sell', according to Bloomberg data. The average 12-month analysts' consensus price target implies an upside of 10.9%.
